Rockwell Medical Q2 FY26 net loss narrows 20% to USD 1.2 million; net sales rise 11% to USD 17.8 million
RMTI•Q2 results and outlook
- Rockwell Medical posted Q2 net sales of USD 17.8 million, up 11% year over year.
- Net loss narrowed to USD 1.2 million; gross margin rose 2 percentage points to 18%.
- Adjusted EBITDA loss under non-GAAP held at USD 0.2 million.
- Cash, cash equivalents, and available-for-sale investments totaled USD 24.8 million at June 30.
- Reiterated 2026 outlook: net sales USD 70 million-USD 75 million; adjusted EBITDA USD 1 million-USD 2 million.
